All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
AN2 THERAPEUTICS, INC. Last Reported: 1/31/2024 Stock Symbol: ANTX

Business Address

1800 EL CAMINO REAL, SUITE D

MENLO PARK , CA US 94027

Mailing Address

1800 EL CAMINO REAL, SUITE D

MENLO PARK , CA US 94027
Phone Number: (650) 331-9090 / State Incorporated: DE / Fiscal Year End 12 /31

Balance Sheet

Date 9/30/2023 6/30/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020
Cash and Cash Equivalents $32,600,000.00 $40,812,000.00 $27,219,000.00 $28,800,000.00 $40,616,000.00 $82,519,000.00 $12,097,000.00 -- -- -- --
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $2,591,000.00 $2,935,000.00 $2,509,000.00 $2,841,000.00 $3,475,000.00 $1,397,000.00 $1,551,000.00 -- -- -- --
Total Current Assets $126,409,000.00 $98,206,000.00 $98,621,000.00 $107,296,000.00 $116,877,000.00 $119,783,000.00 $60,106,000.00 -- -- -- --
Property Plant and Equipement -- -- -- -- -- -- -- -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- --
Other Assets $1,043,000.00 $720,000.00 $720,000.00 $720,000.00 $720,000.00 $720,000.00 -- -- -- -- --
Total Assets $153,808,000.00 $98,926,000.00 $102,560,000.00 $110,008,000.00 $120,016,000.00 $120,503,000.00 $65,316,000.00 -- -- -- --
Accounts Payable $4,877,000.00 $3,131,000.00 $2,122,000.00 $1,440,000.00 $1,612,000.00 $2,609,000.00 $1,063,000.00 -- -- -- --
Accrued Liabilities $6,790,000.00 $6,443,000.00 $2,837,000.00 $1,805,000.00 $1,802,000.00 $2,101,000.00 $1,399,000.00 -- -- -- --
Total Current Liabilities $14,839,000.00 $11,162,000.00 $7,188,000.00 $4,435,000.00 $4,153,000.00 $5,093,000.00 $3,408,000.00 -- -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss $-122,000.00 $-119,000.00 $-374,000.00 $-541,000.00 $-360,000.00 $-158,000.00 $-27,000.00 -- -- -- --
Accumulated Deficit $-137,557,000.00 $-120,850,000.00 $-89,723,000.00 $-77,881,000.00 $-66,542,000.00 $-56,422,000.00 $-47,384,000.00 -- -- -- --
Total Stockholders' Equity $138,969,000.00 $87,764,000.00 $95,372,000.00 $105,573,000.00 $115,863,000.00 $115,410,000.00 $-47,411,000.00 $-38,349,000.00 $-29,842,000.00 $-23,114,000.00 $-20,319,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $153,808,000.00 $98,926,000.00 $102,560,000.00 $110,008,000.00 $120,016,000.00 $120,503,000.00 $65,316,000.00 -- -- -- --

Statement of Operations

Date 9/30/2023 6/30/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020
Total Revenues -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- --
Research and Development $14,429,000.00 $25,523,000.00 $28,511,000.00 $7,428,000.00 $12,331,000.00 $5,633,000.00 -- $5,345,000.00 $5,499,000.00 $1,649,000.00 --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $18,180,000.00 $32,640,000.00 $42,262,000.00 $29,786,000.00 $10,333,000.00 $7,683,000.00 -- $6,932,000.00 $4,998,000.00 $2,050,000.00 --
Loss from Operations $-18,180,000.00 $-16,601,000.00 $-42,262,000.00 $-11,770,000.00 $-18,016,000.00 $-7,683,000.00 -- $-13,980,000.00 $-7,048,000.00 $-2,050,000.00 --
Loss Before Income Taxes -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic $-2.22 $-1.60 $-2.79 $-0.59 $-1.74 -- -- $-3.35 $-3.70 -- --
Weighted Average Shares Basic 21,532,537 19,442,010 15,340,134 19,347,148 11,263,804 -- -- 2,632,919 2,633,954 -- --
Earnings Per Share Diluted $-2.22 $-1.60 $-2.79 $-2.21 $-0.53 -- -- $-7.06 $-2.62 -- --
Weighted Average Shares Diluted 21,532,537 19,497,494 15,340,134 19,347,148 19,258,066 -- -- 2,632,919 2,627,349 -- --
Common Stock Shares Authorized 500,000,000 500,000,000 500,000,000 500,000,000 500,000,000 500,000,000 17,166,642 -- -- -- --
Common Stock Shares Outstanding 29,741,445 21,928,452 19,402,658 19,402,658 19,402,658 18,712,658 2,730,298 -- -- -- --
Common Stock Value -- -- -- -- -- -- -- -- -- -- --
Common Stock Par Or Stated Value Per Share -- -- -- -- -- -- -- -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share -- -- -- -- -- -- -- -- -- -- --
Share Price -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com